Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 202

Sort by

Sort Order Select

Journal Articles

Application of Stem Cell Boost for Immune Effector Cell Associated Hematotoxicity (ICAHT) Following BCMA Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Multiple Myeloma (MM)

Blood (2024) 144 (Supplement 1): 254.

https://doi.org/10.1182/blood-2024-210725

Published: 2024

Journal Articles

Socioeconomic Disparities in Allogeneic Hematopoietic Cell Transplant Outcomes

Moazzam Shahzad, Zouina Sarfraz, Ben Ponvilawan, Muhammad Kashif Amin, Ankita Gupta, Matthew McGuirk, Sibgha Gull Chaudhary, Iqra Anwar, Leyla O. Shune, Joseph P. McGuirk, Mehdi Hamadani, Muhammad Umair Mushtaq

Blood (2024) 144 (Supplement 1): 3556.

https://doi.org/10.1182/blood-2024-194451

Published: 2024

Journal Articles

Sociodemographic and Patient-Related Determinants of Outcomes after Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based GvHD Prophylaxis

Sibgha Gull Chaudhary, Moazzam Shahzad, Kayla Pfannenstiell, Muhammad Kashif Amin, Amir Kasaeian, Muhammad Fareed Khalid, Hediyeh Alemi, Naghmeh Khavandgar, Iqra Anwar, Matthew McGuirk, Syed Nasir Abbas Bukhari, Anurag K. Singh, Mehdi Hamadani, Joseph P. McGuirk, Muhammad Umair Mushtaq

Blood (2024) 144 (Supplement 1): 3524.

https://doi.org/10.1182/blood-2024-202271

Published: 2024

Journal Articles

Cytogenetic Abnormalities Following CAR T Cell Therapy for B-Cell Malignancies

Na Hyun Kim, Fatima Khamissi, Kathleen Bone, Nathan Kopp, Walter Longo, Bryon D. Johnson, Tyce Kearl, Peiman Hematti, Mehdi Hamadani, Timothy S. Fenske, Nirav N. Shah

Blood (2024) 144 (Supplement 1): 3459.

https://doi.org/10.1182/blood-2024-205752

Published: 2024

Journal Articles

Sociodemographic and Patient-Related Determinants of Outcomes after Allogeneic Hematopoietic Cell Transplantation in Acute Leukemia and Myelodysplastic Syndromes

Muhammad Umair Mushtaq, Aleenah Mohsin, Sibgha Gull Chaudhary, Muhammad Kashif Amin, Iqra Anwar, Matthew McGuirk, Syed Nasir Abbas Bukhari, Kayla Pfannenstiell, Anurag K. Singh, Mehdi Hamadani, Joseph P. McGuirk, Moazzam Shahzad

Blood (2024) 144 (Supplement 1): 7902.

https://doi.org/10.1182/blood-2024-200443

Published: 2024

Journal Articles

Impact of Obesity on Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation

Moazzam Shahzad, Aleenah Mohsin, Aqeeb Ur Rehman, Sohaib Irfan, Muhammad Atif Khan, Muhammad Kashif Amin, Matthew McGuirk, Sibgha Gull Chaudhary, Faiza Humayun Khan, Iqra Anwar, Nausheen Ahmed, Al-Ola Abdallah, Mehdi Hamadani, Joseph P. McGuirk, Muhammad Umair Mushtaq

Blood (2024) 144 (Supplement 1): 7421.

https://doi.org/10.1182/blood-2024-193485

Published: 2024

Journal Articles

Impact of Graft Cell Dose on Outcomes after Matched Sibling Donor Bone Marrow Transplantation with Post-Transplant Cyclophosphamide-Based GvHD Prophylaxis

Moazzam Shahzad, Amir Kasaeian, Muhammad Kashif Amin, Muhammad Fareed Khalid, Naghmeh Khavandgar, Hediyeh Alemi, Sibgha Gull Chaudhary, Iqra Anwar, Matthew McGuirk, Sunil Abhyankar, Mehdi Hamadani, Joseph P. McGuirk, Muhammad Umair Mushtaq

Blood (2024) 144 (Supplement 1): 7277.

https://doi.org/10.1182/blood-2024-199953

Published: 2024

Journal Articles

Factors Associated with Acute and Chronic Graft-Versus-Host Disease after Matched Unrelated Donor Hematopoietic Cell Transplantation Using Posttransplant Cyclophosphamide-Based GvHD Prophylaxis

Moazzam Shahzad, Aqeeb Ur Rehman, Muhammad Kashif Amin, Aleenah Mohsin, Sibgha Gull Chaudhary, Iqra Anwar, Jawad Noor, Rajat Bansal, Matthew McGuirk, Anurag K. Singh, Mehdi Hamadani, Joseph P. McGuirk, Muhammad Umair Mushtaq

Blood (2024) 144 (Supplement 1): 2147.

https://doi.org/10.1182/blood-2024-199533

Published: 2024

Journal Articles

Impact of Conditioning Intensity on Outcomes after Allogeneic Related Donor HCT with Post-Transplant Cyclophosphamide-Based Gvhd Prophylaxis in Acute Leukemia and Myelodysplastic Syndromes

Muhammad Umair Mushtaq, Amir Kasaeian, Muhammad Kashif Amin, Aqeeb Ur Rehman, Naghmeh Khavandgar, Hediyeh Alemi, Sibgha Gull Chaudhary, Iqra Anwar, Matthew McGuirk, Haitham Abdelhakim, Anurag K. Singh, Mehdi Hamadani, Joseph P. McGuirk, Moazzam Shahzad

Blood (2024) 144 (Supplement 1): 2141.

https://doi.org/10.1182/blood-2024-199413

Published: 2024

Journal Articles

Impact of Minimal Residual Disease Status on Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia

Moazzam Shahzad, Sohaib Irfan, Muhammad Kashif Amin, Muhammad Jawad Javed, Matthew McGuirk, Sibgha Gull Chaudhary, Iqra Anwar, Zobia Farooq, Abdulraheem Yacoub, Anurag K. Singh, Mehdi Hamadani, Joseph P. McGuirk, Muhammad Umair Mushtaq

Blood (2024) 144 (Supplement 1): 3552.

https://doi.org/10.1182/blood-2024-193477

Published: 2024

Journal Articles

Factors Associated with Graft-Versus-Host Disease after Related Donor Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based GvHD Prophylaxis

Muhammad Umair Mushtaq, Amir Kasaeian, Muhammad Kashif Amin, Hediyeh Alemi, Naghmeh Khavandgar, Aqeeb Ur Rehman, Sibgha Gull Chaudhary, Matthew McGuirk, Al-Ola Abdallah, Anurag K. Singh, Sunil Abhyankar, Mehdi Hamadani, Joseph P. McGuirk, Moazzam Shahzad

Blood (2024) 144 (Supplement 1): 3517.

https://doi.org/10.1182/blood-2024-199559

Published: 2024

Journal Articles

Sociodemographic and Patient-Related Determinants of Outcomes after Matched Sibling Donor Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based GvHD Prophylaxis

Sibgha Gull Chaudhary, Moazzam Shahzad, Kayla Pfannenstiell, Muhammad Kashif Amin, Amir Kasaeian, Naghmeh Khavandgar, Hediyeh Alemi, Sohaib Irfan, Matthew McGuirk, Syed Nasir Abbas Bukhari, Anurag K. Singh, Mehdi Hamadani, Muhammad Umair Mushtaq

Blood (2024) 144 (Supplement 1): 2122.

https://doi.org/10.1182/blood-2024-202260

Published: 2024

Journal Articles

Impact of CD34+ Graft Cell Dose on Outcomes after Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide-Based Gvhd Prophylaxis

Sibgha Gull Chaudhary, Moazzam Shahzad, Amir Kasaeian, Muhammad Fareed Khalid, Muhammad Kashif Amin, Naghmeh Khavandgar, Hediyeh Alemi, Matthew McGuirk, Kayla Pfannenstiell, Syed Nasir Abbas Bukhari, Sunil Abhyankar, Mehdi Hamadani, Joseph P. McGuirk, Muhammad Umair Mushtaq

Blood (2024) 144 (Supplement 1): 3503.

https://doi.org/10.1182/blood-2024-201994

Published: 2024

Journal Articles

Outcomes after Bone Marrow Versus Peripheral Blood Matched Sibling Donor Hematopoietic Cell Transplantation Using Posttransplant Cyclophosphamide-Based Gvhd Prophylaxis

Muhammad Umair Mushtaq, Amir Kasaeian, Sibgha Gull Chaudhary, Muhammad Kashif Amin, Hediyeh Alemi, Naghmeh Khavandgar, Iqra Anwar, Sohaib Irfan, Matthew McGuirk, Al-Ola Abdallah, Anurag K. Singh, Mehdi Hamadani, Joseph P. McGuirk, Moazzam Shahzad

Blood (2024) 144 (Supplement 1): 2119.

https://doi.org/10.1182/blood-2024-200031

Published: 2024

Journal Articles

Superiority of Post-Transplant Cyclophosphamide-Based Graft Versus Host Disease (GvHD) Prophylaxis in Patients 70 Years and Older: A BMT CTN 1703 Post-Hoc Analysis

Blood (2024) 144 (Supplement 1): 1042.

https://doi.org/10.1182/blood-2024-193827

Published: 2024

Journal Articles

Early Safety and Feasibility Results from a Phase II Trial of De-Escalated Ptcy and Ruxolitinib for Gvhd Prophylaxis in Older Patients Undergoing Reduced Intensity Conditioning Allogeneic HCT

Sameem Abedin, Fateeha Furqan, Lyndsey Runaas, Walter Longo, Nirav N. Shah, Timothy S. Fenske, Marcelo C. Pasquini, William R Drobyski, Xue-Zhong Yu, Mehdi Hamadani

Blood (2024) 144 (Supplement 1): 1039.

https://doi.org/10.1182/blood-2024-200832

Published: 2024

Journal Articles

Real-World Early Outcomes of Second-Line Axicabtagene Ciloleucel (Axi-Cel) Therapy in Patients (Pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL)

Blood (2024) 144 (Supplement 1): 526.

https://doi.org/10.1182/blood-2024-199139

Published: 2024

Journal Articles

Outcomes after Matched Sibling Donor Versus Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based GvHD Prophylaxis

Muhammad Umair Mushtaq, Amir Kasaeian, Sibgha Gull Chaudhary, Muhammad Kashif Amin, Hediyeh Alemi, Naghmeh Khavandgar, Iqra Anwar, Ahmad Basharat, Matthew McGuirk, Peiman Hematti, Al-Ola Abdallah, Anurag K. Singh, Mehdi Hamadani, Joseph P. McGuirk, Moazzam Shahzad

Blood (2024) 144 (Supplement 1): 2102.

https://doi.org/10.1182/blood-2024-200022

Published: 2024

Journal Articles

Phase 1 Study of Trispecific Anti-CD20, Anti-CD19, Anti-CD22 (CAR20.19.22) T Cells for Relapsed, Refractory B-Cell Malignancies

Nirav N. Shah, Aniko Szabo, Tyce Kearl, Dina Schneider, Walter Longo, Bryon D. Johnson, Peiman Hematti, Mehdi Hamadani, Timothy S. Fenske

Blood (2024) 144 (Supplement 1): 3448.

https://doi.org/10.1182/blood-2024-200899

Published: 2024

Journal Articles

Impact of Systemic Antibiotics Use on Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation

Moazzam Shahzad, Sohaib Irfan, Muhammad Atif Khan, Muhammad Kashif Amin, Matthew McGuirk, Sibgha Gull Chaudhary, Faiza Humayun Khan, Iqra Anwar, Peiman Hematti, Mehdi Hamadani, Joseph P. McGuirk, Muhammad Umair Mushtaq

Blood (2024) 144 (Supplement 1): 7409.

https://doi.org/10.1182/blood-2024-193482

Published: 2024

NARROW

Application of Stem Cell Boost for Immune Effector Cell Associated Hematotoxicity (ICAHT) Following BCMA Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Multiple Myeloma (MM)

Socioeconomic Disparities in Allogeneic Hematopoietic Cell Transplant Outcomes

Sociodemographic and Patient-Related Determinants of Outcomes after Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based GvHD Prophylaxis

Cytogenetic Abnormalities Following CAR T Cell Therapy for B-Cell Malignancies

Sociodemographic and Patient-Related Determinants of Outcomes after Allogeneic Hematopoietic Cell Transplantation in Acute Leukemia and Myelodysplastic Syndromes

Impact of Obesity on Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation

Impact of Graft Cell Dose on Outcomes after Matched Sibling Donor Bone Marrow Transplantation with Post-Transplant Cyclophosphamide-Based GvHD Prophylaxis

Factors Associated with Acute and Chronic Graft-Versus-Host Disease after Matched Unrelated Donor Hematopoietic Cell Transplantation Using Posttransplant Cyclophosphamide-Based GvHD Prophylaxis

Impact of Conditioning Intensity on Outcomes after Allogeneic Related Donor HCT with Post-Transplant Cyclophosphamide-Based Gvhd Prophylaxis in Acute Leukemia and Myelodysplastic Syndromes

Impact of Minimal Residual Disease Status on Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia

Factors Associated with Graft-Versus-Host Disease after Related Donor Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based GvHD Prophylaxis

Sociodemographic and Patient-Related Determinants of Outcomes after Matched Sibling Donor Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based GvHD Prophylaxis

Impact of CD34+ Graft Cell Dose on Outcomes after Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide-Based Gvhd Prophylaxis

Outcomes after Bone Marrow Versus Peripheral Blood Matched Sibling Donor Hematopoietic Cell Transplantation Using Posttransplant Cyclophosphamide-Based Gvhd Prophylaxis

Superiority of Post-Transplant Cyclophosphamide-Based Graft Versus Host Disease (GvHD) Prophylaxis in Patients 70 Years and Older: A BMT CTN 1703 Post-Hoc Analysis

Early Safety and Feasibility Results from a Phase II Trial of De-Escalated Ptcy and Ruxolitinib for Gvhd Prophylaxis in Older Patients Undergoing Reduced Intensity Conditioning Allogeneic HCT

Real-World Early Outcomes of Second-Line Axicabtagene Ciloleucel (Axi-Cel) Therapy in Patients (Pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL)

Outcomes after Matched Sibling Donor Versus Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based GvHD Prophylaxis

Phase 1 Study of Trispecific Anti-CD20, Anti-CD19, Anti-CD22 (CAR20.19.22) T Cells for Relapsed, Refractory B-Cell Malignancies

Impact of Systemic Antibiotics Use on Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only